Exencial Wealth Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$537K Sell
1,834
-112
-6% -$36.8K 0.02% 385
2025
Q4
$682K Buy
+1,946
New +$658K 0.02% 344
2025
Q2
Sell
-469
Closed -$204K 499
2025
Q1
$204K Buy
+469
New +$188K 0.01% 483
2022
Q1
Sell
-702
Closed -$325K 462
2021
Q4
$325K Buy
702
+5
+0.7% +$2.1K 0.02% 377
2021
Q3
$260K Sell
697
-353
-34% -$134K 0.01% 292
2021
Q2
$401K Buy
+1,050
New +$401K 0.02% 344
2019
Q3
Sell
-933
Closed -$263K 248
2019
Q2
$263K Hold
933
0.06% 191
2019
Q1
$268K Sell
933
-280
-23% -$81K 0.06% 189
2018
Q4
$319K Buy
+1,213
New +$334K 0.09% 162

Other funds holding ELV

Exencial Wealth Advisors's ELV Position: Q1 2026 in Review

Exencial Wealth Advisors reduced its Elevance Health (ELV) stake by 5.8% in Q1 2026, selling an estimated $36.8K and leaving 1,834 shares worth $537K. The position accounts for 0.02% of the portfolio, ranked #385.

Exencial Wealth Advisors first reported a position in ELV in Q4 2018 and has held it in 9 quarters since. The position peaked at $682K in Q4 2025. 1,470 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Exencial Wealth Advisors held 1,834 shares of Elevance Health worth $537K as of Q1 2026.
  • Exencial Wealth Advisors sold 112 Elevance Health shares in Q1 2026, an estimated $36.8K.
  • Elevance Health made up 0.02% of Exencial Wealth Advisors's portfolio in Q1 2026, its #385 holding.
  • Exencial Wealth Advisors first reported a position in Elevance Health in Q4 2018 and has held it in 9 quarters since.
  • Exencial Wealth Advisors's Elevance Health position peaked at $682K in Q4 2025.
  • 1,470 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Exencial Wealth Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.